Marshall Wace, LLP Exscientia PLC Transaction History

Marshall Wace, LLP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$5.3 - $7.51 $1.61 Million - $2.29 Million	-304,593 Reduced 23.43%	995,475 $5.69 Million
Q4 2023 Feb 14, 2024	SELL	$4.35 - $6.88 $72,070 - $113,987	-16,568 Reduced 1.26%	1,300,068 $8.33 Million
Q3 2023 Nov 14, 2023	SELL	$4.52 - $8.9 $490,474 - $965,756	-108,512 Reduced 7.61%	1,316,636 $5.95 Million
Q1 2023 May 15, 2023	SELL	$5.3 - $10.93 $1.29 Million - $2.65 Million	-242,824 Reduced 14.56%	1,425,148 $7.55 Million
Q4 2022 Feb 14, 2023	BUY	$4.1 - $8.94 $118,293 - $257,936	28,852 Added 1.76%	1,667,972 $8.89 Million
Q3 2022 Nov 14, 2022	BUY	$7.27 - $12.92 $185,777 - $330,157	25,554 Added 1.58%	1,639,120 $13.5 Million
Q2 2022 Aug 15, 2022	BUY	$6.92 - $15.97 $5.62 Million - $13 Million	812,649 Added 101.46%	1,613,566 $17.6 Million
Q1 2022 May 16, 2022	SELL	$11.52 - $22.05 $279,475 - $534,933	-24,260 Reduced 2.94%	800,917 $11.5 Million
Q4 2021 Feb 14, 2022	BUY	$17.63 - $27.1 $14.5 Million - $22.4 Million	825,177 New	825,177 $16.3 Million

101

33.5M

500

189K

Ticker EXAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 122,461,000
Market Cap $593M
Description
Exscientia plc, an artificial intelligence-driven pharmatech company, engages in discovering, designing, and developing drugs. The company offers end-to-end solution of artificial intelligence (AI) and technologies for target identification, drug candidate design, translational models, and patient selection. In addition, the company focuses on s...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.